Business
Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results
Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56%
About this update from Astrana Health Inc.
[{"type":"text","content":"Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. (\"Astrana,\" and together with its subsidiaries and affiliated entities, the \"Company\") (NASDAQ: ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2025.\n \n \n \n \n \n \n \n\"Astrana delivered record revenue, adjusted EBITDA, and free cash flow in 2025, demonstrating the strength and predictability of our fully delegated, payer-agnostic care model and AI-enabled technology platform in a dynamic operating environment,\" said Brandon Sim, President and Chief Executive Officer of Astrana Health. \"Our disciplined approach to risk, strong physician alignment, and technology-enabled clinical infrastructure drove consistent performance while creating measurable value for patients through improved outcomes, greater access, and lower total cost of care. As we move through 2026, with Prospect Health integration ahead of schedule, we are confident in our ability to deliver on guidance that reflects approximately 24% revenue growth and 29% adjusted EBITDA growth at the midpoint.\"Financial Highlights for Year Ended December 31, 2025:All comparisons are to the year ended December 31, 2024 unless otherwise stated.Total revenue of $3,181.8 million, up 56% from $2,034.5 millionCare Partners revenue of $3,022.6 million, up 55% from $1,949.0 millionNet income attributable to Astrana of $22.5 millionEarnings per share (\"EPS\") - diluted of $0.46Adjusted EBITDA(2) of $205.4 million, up 21% from $170.4 millionAdjusted EPS - diluted(3) of $2.20Financial Highlights for the Fourth Quarter 2025:All comparisons are to the quarter ended December 31, 2024 unless otherwise stated.Total revenue of $950.5 million, up 43% from $665.2 millionCare Partners revenue of $892.5 million up 38% from $647.7 millionNet income attributable to Astrana of $6.0 millionEP...